A carregar...
Targeting the protein-protein interaction between IRS1 and mutant p110α for cancer therapy
PIK3CA, which encodes the catalytic p110α subunit of phosphatidylinositol 3-kinase α, is the most frequently mutated oncogene in human cancers. Targeting mutant p110α holds great promise for cancer therapy. However, it is challenging to develop p110α isoform-specific inhibitors. Most p110α mutations...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3916152/ https://ncbi.nlm.nih.gov/pubmed/24178578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0192623313506794 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|